The mechanism involves shifting melanogenesis from eumelanin (dark pigment) to pheomelanin (lighter pigment) and disrupting the binding between tyrosinase and L-DOPA (Abidin et al., 2025)
However, compelling evidence suggests that, for the majority of ROS-related anticancer drugs, apoptosis depends on the activation of the intrinsic pathway that involves mitochondrial PTPs, the permeability of which is increased with the cytoplasmic release of pro-apoptotic factors such as cytochrome c that forms a complex with apoptotic protease activating factor 1 (Apaf-1) and pro-caspase 9 to build the apoptosome, activating, in turn, effector caspases 77,78,79,80 (Fig
Butterwick is fantastic, all of her team as well
Retrieved from Yang, M., Liu, S., & Zhang, C
Hetz C, Saxena S
the no-DAC form has none, and the two are not interchangeable